Beyond the Clinical Trial: How AI is Uncovering Hidden Patient Experiences with GLP-1 Drugs

In the rapidly evolving landscape of metabolic medicine, a new class of drugs—the glucagon-like peptide-1 (GLP-1) receptor agonists, including Ozempic, Wegovy, Mounjaro, and Zepbound—has achieved a level of cultural and…